Physica Status Solidi (A) Applications and Materials

ISSN
P 1862-6300 E 1862-6319
출판사
Wiley - V C H Verlag GmbbH & Co. Wiley-Blackwell
국가
GERMANY
발행 상태
활성

데이터베이스 수록 정보

JCR 2008-2019 (12년)
SCI 2010-2019 (10년)
SCIE 2010-2021 (12년)
Scopus 2017-2020 (4년)
SJR 1999-2019 (21년)

전체 21건 중 1번부터 10번까지의 결과를 표시합니다.

2025
Article

Clinical significance of earlier CHR achievement and long-term CHR maintenance in polycythemia vera patients treated with ropeginterferon alfa-2b

  • Lee, Sung-Eun
  • Yoon, Sung-Soo
  • Yang, Deok-Hwan
  • Lee, Gyeong-Won
  • Yoon, Seug Yun
  • 외 11명
  • 2025-11
  • Blood
  • American Society of Hematology
Article

Phase II study of lenalidomide in combination with rituximab, cyclophosphadmie, doxorubicin, vincristine, and prenisone (R-CHOP) for central nervous system prophylaxis in high-risk diffuse large B cell lymphoma

  • Cho, Hyungwoo
  • Hyung, Jaewon
  • Eom, Hyeon-Seok
  • Lim, Sung-Nam
  • Kang, Hye Jin
  • ... Lee, Gyeong-Won
  • 외 10명
  • 2025-11
  • Blood
  • American Society of Hematology
Article

Rapid JAK2 V617F decline predicts response durability: Kinetics of JAK2 V617F in ropeginterferon alfa-2b treated polycythemia vera

  • Lee, Sung-Eun
  • Yoon, Sung-Soo
  • Yang, Deok-Hwan
  • Lee, Gyeong-Won
  • Yoon, Seug Yun
  • 외 11명
  • 2025-11
  • Blood
  • American Society of Hematology
Article

Transcriptomic signatures associated with deep molecular response to ropeginterferon alfa-2b in polycythemia vera

  • Yoon, Seug Yun
  • Yoon, Sung-Soo
  • Yang, Deok-Hwan
  • Lee, Gyeong-Won
  • Sohn, Sang Kyun
  • 외 10명
  • 2025-11
  • Blood
  • American Society of Hematology
Article

Phase I/II study of zanubrutinib in combination with rituximab, ifosfamide, carboplatin, and etoposide (ZR-ICE) in Relapsed/Refractory diffuse large B-cell lymphoma: Results of the Phase I portion

  • Cho, Hyungwoo
  • Hyung, Jaewon
  • Baek, Dong Won
  • Lee, Ho Sup
  • Kang, Hye Jin
  • ... Lee, Gyeong-Won
  • 외 11명
  • 2025-11
  • Blood
  • American Society of Hematology
2024
Article

Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon

  • Yoon, Seug Yun
  • Won, Jong-Ho
  • Lee, Sung-Eun
  • Yoon, Sung-Soo
  • Yang, Deok-Hwan
  • ... Lee, Gyeong Won
  • 외 11명
  • 2024-11
  • Blood
  • ELSEVIER
Article

Ropeginterferon in Low-Risk Patients with Polycythemia Vera

  • Lee, Ji Yun
  • Lee, Sung-Eun
  • Yoon, Sung-Soo
  • Yang, Deok-Hwan
  • Sohn, Sang Kyun
  • ... Lee, Gyeong Won
  • 외 6명
  • 2024-11
  • Blood
  • American Society of Hematology
Article

Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea

  • Lee, Sung-Eun
  • Yoon, Sung-Soo
  • Yang, Deok-Hwan
  • Lee, Gyeong Won
  • Yoon, Seug Yun
  • 외 11명
  • 2024-11
  • Blood
  • American Society of Hematology
Article

Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b

  • Lee, Sung-Eun
  • Yoon, Sung-Soo
  • Yang, Deok-Hwan
  • Lee, Gyeong Won
  • Yoon, Seug Yun
  • 외 11명
  • 2024-11
  • Blood
  • ELSEVIER
1